Related references
Note: Only part of the references are listed.Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes
Wei Qiang et al.
NATURE (2017)
Ligand and Target Discovery by Fragment-Based Screening in Human Cells
Christopher G. Parker et al.
CELL (2017)
Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy
Marcia Waddington Cruz et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Julian D. Gillmore et al.
CIRCULATION (2016)
Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis
Laura Obici et al.
CURRENT OPINION IN NEUROLOGY (2016)
Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation
Lars Plate et al.
ELIFE (2016)
A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells
Micah J. Niphakis et al.
CELL (2015)
Tafamidis in Transthyretin Amyloid Cardiomyopathy Effects on Transthyretin Stabilization and Clinical Outcomes
Mathew S. Maurer et al.
CIRCULATION-HEART FAILURE (2015)
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis
Julien Marcoux et al.
EMBO MOLECULAR MEDICINE (2015)
Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments
Yoshiki Sekijima
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Engineering of a peptide probe for β-amyloid aggregates
Edwin Aoraha et al.
MOLECULAR BIOSYSTEMS (2015)
Amyloid Polymorphism: Structural Basis and Neurobiological Relevance
Robert Tycko
NEURON (2015)
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Bo-Goran Ericzon et al.
TRANSPLANTATION (2015)
Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition
Sandra Arvidsson et al.
PLOS ONE (2015)
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials
N. Suanprasert et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies
David W. Sanders et al.
NEURON (2014)
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis
P. Patrizia Mangione et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient
Mariana Seca et al.
CASE REPORTS IN OPHTHALMOLOGY (2014)
Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial
John L. Berk et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
Teresa Coelho et al.
JOURNAL OF NEUROLOGY (2013)
Liver transplantation and transthyretin amyloidosis
Merrill D. Benson
MUSCLE & NERVE (2013)
Guideline of transthyretin-related hereditary amyloidosis for clinicians
Yukio Ando et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Genotype - phenotype correlation in FAP
Steven R. Zeldenrust
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
The Amyloid State of Proteins in Human Diseases
David Eisenberg et al.
CELL (2012)
Transthyretin (TTR) Cardiac Amyloidosis
Frederick L. Ruberg et al.
CIRCULATION (2012)
Transthyretin Amyloidosis and the Kidney
Luisa Lobato et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Tafamidis for transthyretin familial amyloid polyneuropathy A randomized, controlled trial
Teresa Coelho et al.
NEUROLOGY (2012)
Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
W. Lamm et al.
ANNALS OF HEMATOLOGY (2011)
Dissecting the Structure, Thermodynamic Stability, and Aggregation Properties of the A25T Transthyretin (A25T-TTR) Variant Involved in Leptomeningeal Amyloidosis: Identifying Protein Partners That Co-Aggregate during A25T-TTR Fibrillogenesis in Cerebrospinal Fluid
Estefania P. C. Azevedo et al.
BIOCHEMISTRY (2011)
Sulfated Ligands for the Copper(I)-Catalyzed Azide-Alkyne Cycloaddition
Wei Wang et al.
CHEMISTRY-AN ASIAN JOURNAL (2011)
Familial amyloid polyneuropathy
Violaine Plante-Bordeneuve et al.
LANCET NEUROLOGY (2011)
A Strategy for Designing a Peptide Probe for Detection of β-Amyloid Oligomers
Yang Hu et al.
CHEMBIOCHEM (2010)
Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis
Efstathios Kastritis et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Chemical Probes That Selectively Recognize the Earliest Aβ Oligomers in Complex Mixtures
Ashley A. Reinke et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Usefulness of labial salivary gland biopsy in familial amyloid polyneuropathy Portuguese type
Barbas Do Amaral et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2009)
Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags
Loic Dayon et al.
ANALYTICAL CHEMISTRY (2008)
Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)
V. Plante-Bordeneuve et al.
NEUROLOGY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Adaptive linear step-up procedures that control the false discovery rate
Yoav Benjamini et al.
BIOMETRIKA (2006)
Amyloid deposits in transthyretin-derived amyloidosis:: cleaved transthyretin is associated with distinct amyloid morphology
J Bergström et al.
JOURNAL OF PATHOLOGY (2005)
Profiling enzyme activities in vivo using click chemistry methods
AE Speers et al.
CHEMISTRY & BIOLOGY (2004)
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture
N Reixach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Activity-based protein profiling in vivo using a copper(I)-catalyzed azide-alkyne [3+2] cycloaddition
AE Speers et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Trans-suppression of misfolding in an amyloid disease
P Hammarström et al.
SCIENCE (2001)
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured
X Jiang et al.
BIOCHEMISTRY (2001)
Share Paper
